サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1625446

動物用抗生物質の市場、シェア、規模、動向、産業分析レポート：動物タイプ別、薬剤クラス別、剤形別、地域別 - 市場予測、2025年～2034年

Veterinary Antibiotics Market Share, Size, Trends, Industry Analysis Report: By Animal Type, Drug Class, Dosage Form, and Region - Market Forecast, 2025-2034

出版日
ページ情報
英文 122 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
動物用抗生物質の市場、シェア、規模、動向、産業分析レポート：動物タイプ別、薬剤クラス別、剤形別、地域別 - 市場予測、2025年～2034年
出版日: 2024年12月01日
発行: Polaris Market Research
ページ情報: 英文 122 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界の動物用抗生物質市場規模は2034年までに64億3,000万米ドルに達する見込みです。このレポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

動物用抗生物質は、動物の細菌感染を治療するために特別に設計された薬です。抗生物質は有害な細菌を除去したり、その増殖を抑制したりして、動物の回復を助ける。

大手企業の取り組みや新製品のイントロダクションより、動物用抗生物質やイオノフォアへの注目が高まっています。家畜の病気は増加傾向にあり、主要企業は需要に応えるために新しい抗生物質を積極的にリリースしています。

動物用抗生物質市場は、人獣共通感染症に対する意識の高まり、動物疾病発生の増加、動物由来の食品需要の増加により、予測期間中に成長すると予想されます。さらに、厳しい疾病予防規制、動物人口の増加、ペット飼育の増加、ペット健康保険市場の拡大が市場成長を促進しています。

コンパニオンアニマルの飼育が増加していることが、抗生物質を含む獣医療サービスおよび製品の需要を促進しています。ペットを家に迎える人が増えるにつれ、これらの動物のヘルスケア、予防措置、治療の必要性は世界的に増加し続けています。

2024年7月の中央疾病管理報告書によると、動物と人間の間で感染する人獣共通感染症の予防には、効果的な管理のためのワンヘルスアプローチが必要です。注目すべきは、HIVや狂犬病などの病原体を含め、ヒトの感染症の60％が動物に由来することです。さらに、新興感染症のほとんどと、炭疽などのバイオテロ関連疾患の80％は人獣共通感染症です。動物の間でこのような病気の発生が増加していることが、動物用抗生物質市場の拡大を後押ししています。

動物用抗生物質レポートハイライト

動物タイプ別では、強化された動物の健康管理を必要とする牛肉と乳製品の消費量の増加により、2024年には牛セグメントが動物用抗生物質市場を独占しました。

薬剤クラス別では、2024年にはテトラサイクリン系がその治療用途から市場を独占しました。これらの抗生物質は、食用動物の第一選択治療薬として広く使用されており、犬、猫、馬などの伴侶動物にも頻繁に投与されています。Achromycin、Sumycin、Medicycline、Tetracynなどのテトラサイクリン系薬剤は、特に動物の細菌感染や炎症性皮膚疾患に対処するために獣医学で使用されています。

欧州の獣医市場は、フード、ヘルスケア、グルーミングを含むペットケアへの支出が多いことから、今後数年間で成長すると予想されています。さらに、スマートペットデバイスなどの技術進歩も市場成長に寄与しています。消費者の嗜好の変化、特にダイエットや菜食主義のペットフードに対する需要の増加も市場の成長を支えています。

世界の主要市場企業の一例としては、Merck &Co., Inc.、Ceva Sante Animale、Vetoquinol、Zoetis Services LLC、Boehringer Ingelheim International GmbH、Dechra Pharmaceuticals PLC、Elanco Animal Health Incorporated、Virbac S.A.、Calier、Bimeda, Inc.、Prodivet Pharmaceuticals SA/NV、Norbrook Laboratoriesなどが挙げられます。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の動物用抗生物質市場の洞察

  • 市場スナップショット
  • 動物用抗生物質市場力学
    • 促進要因と機会
      • 動物由来食品の需要増加
      • 家畜疾病の発生増加
    • 抑制要因と課題
      • 厳格な規制枠組み
  • PESTEL分析
  • 動物用抗生物質市場の動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界の動物用抗生物質市場：動物タイプ別

  • 主な調査結果
  • イントロダクション
  • 豚
  • 牛
  • 羊とヤギ
  • 家禽
  • その他

第6章 世界の動物用抗生物質市場：薬剤クラス別

  • 主な調査結果
  • イントロダクション
  • テトラサイクリン
  • ペニシリン
  • スルホンアミド
  • マクロライド
  • トリメトプリム
  • リンコサミド
  • ポリミキシン
  • アミノグリコシド
  • フルオロキノロン
  • プレウロムチリン
  • その他

第7章 世界の動物用抗生物質市場：剤形別

  • 主な調査結果
  • イントロダクション
  • 経口用粉末
  • 経口溶液
  • 注射
  • その他

第8章 世界の動物用抗生物質市場：地域別

  • 主な調査結果
  • イントロダクション
    • 動物用抗生物質市場評価：地域、2020-2034年
  • 北米
    • 北米：動物タイプ別、2020-2034年
    • 北米：薬剤クラス別、2020-2034年
    • 北米：剤形別、2020-2034年
    • 米国
    • カナダ
  • 欧州
    • 欧州：動物タイプ別、2020-2034年
    • 欧州：薬剤クラス別、2020-2034年
    • 欧州：剤形別、2020-2034年
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
    • その他欧州
  • アジア太平洋
    • アジア太平洋地域：動物タイプ別、2020-2034年
    • アジア太平洋地域：薬剤クラス別、2020-2034年
    • アジア太平洋地域：剤形別、2020-2034年
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ
    • 中東・アフリカ：動物タイプ別、2020-2034年
    • 中東・アフリカ：薬剤クラス別、2020-2034年
    • 中東・アフリカ：剤形別、2020-2034年
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ
  • ラテンアメリカ
    • ラテンアメリカ：動物タイプ別、2020-2034年
    • ラテンアメリカ：薬剤クラス別、2020-2034年
    • ラテンアメリカ：剤形別、2020-2034年
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他ラテンアメリカ

第9章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • Bimeda, Inc.
  • Boehringer Ingelheim International GmbH
  • Calier
  • Ceva Sante Animale
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Merck & Co., Inc.
  • Norbrook Laboratories
  • Prodivet Pharmaceuticals SA/NV
  • Vetoquinol
  • Virbac S.A.
  • Zoetis Services LLC
図表

List of Tables:

Table 1 Global Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 2 Global Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 3 Global Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 4 North America: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 5 North America: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 6 North America: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 7 U.S.: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 8 U.S.: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 9 U.S.: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 10 Canada: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 11 Canada: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 12 Canada: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 13 Europe: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 14 Europe: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 15 Europe: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 16 UK: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 17 UK: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 18 UK: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 19 France: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 20 France: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 21 France: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 22 Germany: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 23 Germany: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 24 Germany: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 25 Italy: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 26 Italy: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 27 Italy: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 28 Spain: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 29 Spain: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 30 Spain: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 31 Netherlands: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 32 Netherlands: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 33 Netherlands: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 34 Russia: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 35 Russia: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 36 Russia: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 37 Rest of Europe: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 38 Rest of Europe: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 39 Rest of Europe: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 40 Asia Pacific: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 41 Asia Pacific: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 42 Asia Pacific: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 43 China: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 44 China: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 45 China: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 46 India: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 47 India: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 48 India: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 49 Malaysia: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 50 Malaysia: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 51 Malaysia: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 52 Japan: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 53 Japan: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 54 Japan: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 55 Indonesia: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 56 Indonesia: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 57 Indonesia: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 58 South Korea: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 59 South Korea: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 60 South Korea: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 61 Australia: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 62 Australia: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 63 Australia: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 64 Rest of Asia Pacific: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 65 Rest of Asia Pacific: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 66 Rest of Asia Pacific: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 67 Middle East & Africa: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 68 Middle East & Africa: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 69 Middle East & Africa: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 70 Saudi Arabia: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 71 Saudi Arabia: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 72 Saudi Arabia: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 73 UAE: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 74 UAE: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 75 UAE: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 76 Israel: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 77 Israel: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 78 Israel: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 79 South Africa: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 80 South Africa: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 81 South Africa: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 82 Rest of Middle East & Africa: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 83 Rest of Middle East & Africa: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 84 Rest of Middle East & Africa: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 85 Latin America: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 86 Latin America: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 87 Latin America: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 88 Mexico: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 89 Mexico: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 90 Mexico: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 91 Brazil: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 92 Brazil: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 93 Brazil: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 94 Argentina: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 95 Argentina: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 96 Argentina: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 97 Rest of Latin America: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 98 Rest of Latin America: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 99 Rest of Latin America: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

List of Figures:

Figure 1. Global Veterinary Antibiotics Market, 2020-2034 (USD Billion)

Figure 2. Integrated Ecosystem

Figure 3. Research Methodology: Top-Down & Bottom-Up Price

Figure 4. Market by Geography

Figure 5. Porter's Five Forces

Figure 6. Market by Animal Type

Figure 7. Global Veterinary Antibiotics Market, by Animal Type, 2024 & 2034 (USD Billion)

Figure 8. Market by Drug Class

Figure 9. Global Veterinary Antibiotics Market, by Drug Class, 2024 & 2034 (USD Billion)

Figure 10. Market by Dosage Form

Figure 11. Global Veterinary Antibiotics Market, by Dosage Form, 2024 & 2034 (USD Billion)

目次
Product Code: PM5317

The global veterinary antibiotics market size is expected to reach USD 6.43 billion by 2034, according to a new study by Polaris Market Research. The report "Veterinary Antibiotics Market Share, Size, Trends, Industry Analysis Report: By Animal Type (Pigs, Cattle, Sheep & Goats, Poultry, and Others), Drug Class, Dosage Form, and Region (North America, Europe, Asia Pacific, and Rest of World) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Veterinary antibiotics are medications specifically designed for treating bacterial infections in animals. The antibiotics eliminate harmful bacteria or inhibit their growth, thus assisting in the animal's recovery.

There is a growing emphasis on animal-specific antibiotics and ionophores, driven by initiatives from major companies and the introduction of new products. The incidence of livestock diseases is on the rise, leading key players to actively release new antibiotics to meet demand, especially as older antibiotics have been linked to resistance.

The veterinary antibiotics market is expected to grow during the forecast period due to increased awareness of zoonotic diseases, rising animal disease outbreaks, and higher demand for animal-derived food products. Additionally, stringent disease prevention regulations, a growing animal population, increased pet adoption, and the expanding pet health insurance market are driving the market growth.

The increasing adoption of companion animals is propelling the demand for veterinary services and products, including antibiotics. As more people bring pets into their homes, the need for healthcare, preventive measures, and treatments for these animals continues to increase globally.

According to the central disease control report in July 2024, prevention of Zoonotic diseases, which are transmissible between animals and humans, requires a One Health approach for effective management. Notably, 60% of human infectious diseases originate from animals, including pathogens such as HIV and rabies. Additionally, most emerging infectious diseases and 80% of bioterrorism-related diseases, such as anthrax, are zoonotic. The increasing incidence of such diseases among animals boosts the veterinary antibiotics market expansion.

Veterinary Antibiotics Report Highlights

By animal type, the cattle segment dominated the veterinary antibiotics market in 2024 due to the rising consumption of beef and dairy products that necessitate enhanced animal health management.

Based on drug class, in 2024, the tetracyclines segment dominated the market due to their therapeutic applications. These antibiotics are widely used as first-line treatments for food-producing animals and are also frequently administered to companion animals, including dogs, cats, and horses. Tetracycline-based medications such as Achromycin, Sumycin, Medicycline, and Tetracyn are specifically used in veterinary medicine to address bacterial infections and inflammatory skin conditions in animals.

The European veterinary market is expected to grow in the coming years due to the high expenditure on pet care, encompassing food, healthcare, and grooming. Furthermore, technological advancements such as smart pet devices are contributing to the market growth. Shifting consumer preferences, particularly the increasing demand for dietary and vegan pet food, also support the market growth.

A few global key market players are Merck & Co., Inc.; Ceva Sante Animale; Vetoquinol; Zoetis Services LLC; Boehringer Ingelheim International GmbH; Dechra Pharmaceuticals PLC; Elanco Animal Health Incorporated; Virbac S.A.; Calier, Bimeda, Inc.; Prodivet Pharmaceuticals SA/NV; and Norbrook Laboratories.

Polaris Market Research has segmented the veterinary antibiotics market report on the basis of animal type, drug class, dosage form, and region:

By Animal Type Outlook (Revenue, USD Billion, 2020-2034)

  • Pigs
  • Cattle
  • Sheep & Goats
  • Poultry
  • Others

By Drug Class Outlook (Revenue, USD Billion, 2020-2034)

  • Tetracyclines
  • Penicillins
  • Sulfonamides
  • Macrolides
  • Trimethoprim
  • Lincosamides
  • Polymyxins
  • Aminoglycosides
  • Fluoroquinolones
  • Pleuromutilins
  • Other

By Dosage Form Outlook (Revenue, USD Billion, 2020-2034)

  • Oral Powders
  • Oral Solutions
  • Injections
  • Other

By Regional Outlook (Revenue, USD Billion, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global Veterinary Antibiotics Market Insights

  • 4.1. Veterinary Antibiotics Market - Market Snapshot
  • 4.2. Veterinary Antibiotics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Demand for Animal-Derived Food Products
      • 4.2.1.2. Increasing Incidence of Livestock Diseases
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Strict regulatory framework
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Veterinary Antibiotics Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Veterinary Antibiotics Market, by Animal Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
  • 5.3. Pigs
    • 5.3.1. Global Veterinary Antibiotics Market, by Pigs, by Region, 2020-2034 (USD Billion)
  • 5.4. Cattle
    • 5.4.1. Global Veterinary Antibiotics Market, by Cattle, by Region, 2020-2034 (USD Billion)
  • 5.5. Sheep & Goats
    • 5.5.1. Global Veterinary Antibiotics Market, by Sheep & Goats, by Region, 2020-2034 (USD Billion)
  • 5.6. Poultry
    • 5.6.1. Global Veterinary Antibiotics Market, by Poultry, by Region, 2020-2034 (USD Billion)
  • 5.7. Others
    • 5.7.1. Global Veterinary Antibiotics Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Veterinary Antibiotics Market, by Drug Class

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
  • 6.3. Tetracyclines
    • 6.3.1. Global Veterinary Antibiotics Market, by Tetracyclines, by Region, 2020-2034 (USD Billion)
  • 6.4. Penicillins
    • 6.4.1. Global Veterinary Antibiotics Market, by Penicillins, by Region, 2020-2034 (USD Billion)
  • 6.5. Sulfonamides
    • 6.5.1. Global Veterinary Antibiotics Market, by Sulfonamides, by Region, 2020-2034 (USD Billion)
  • 6.6. Macrolides
    • 6.6.1. Global Veterinary Antibiotics Market, by Macrolides, by Region, 2020-2034 (USD Billion)
  • 6.7. Trimethoprim
    • 6.7.1. Global Veterinary Antibiotics Market, by Trimethoprim, by Region, 2020-2034 (USD Billion)
  • 6.8. Lincosamides
    • 6.8.1. Global Veterinary Antibiotics Market, by Lincosamides, by Region, 2020-2034 (USD Billion)
  • 6.9. Polymyxins
    • 6.9.1. Global Veterinary Antibiotics Market, by Polymyxins, by Region, 2020-2034 (USD Billion)
  • 6.10. Aminoglycosides
    • 6.10.1. Global Veterinary Antibiotics Market, by Aminoglycosides, by Region, 2020-2034 (USD Billion)
  • 6.11. Fluoroquinolones
    • 6.11.1. Global Veterinary Antibiotics Market, by Fluoroquinolones, by Region, 2020-2034 (USD Billion)
  • 6.12. Pleuromutilins
    • 6.12.1. Global Veterinary Antibiotics Market, by Pleuromutilins, by Region, 2020-2034 (USD Billion)
  • 6.13. Others
    • 6.13.1. Global Veterinary Antibiotics Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Veterinary Antibiotics Market, by Dosage Form

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
  • 7.3. Oral Powders
    • 7.3.1. Global Veterinary Antibiotics Market, by Oral Powders, by Region, 2020-2034 (USD Billion)
  • 7.4. Oral Solutions
    • 7.4.1. Global Veterinary Antibiotics Market, by Oral Solutions, by Region, 2020-2034 (USD Billion)
  • 7.5. Injections
    • 7.5.1. Global Veterinary Antibiotics Market, by Injections, by Region, 2020-2034 (USD Billion)
  • 7.6. Others
    • 7.6.1. Global Veterinary Antibiotics Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Veterinary Antibiotics Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Veterinary Antibiotics Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 8.3. Veterinary Antibiotics Market - North America
    • 8.3.1. North America: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
    • 8.3.2. North America: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
    • 8.3.3. North America: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.3.4. Veterinary Antibiotics Market - U.S.
      • 8.3.4.1. U.S.: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.3.4.2. U.S.: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.3.4.3. U.S.: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.3.5. Veterinary Antibiotics Market - Canada
      • 8.3.5.1. Canada: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
  • 8.4. Veterinary Antibiotics Market - Europe
    • 8.4.1. Europe: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.4.4. Veterinary Antibiotics Market - UK
      • 8.4.4.1. UK: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.4.5. Veterinary Antibiotics Market - France
      • 8.4.5.1. France: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.4.6. Veterinary Antibiotics Market - Germany
      • 8.4.6.1. Germany: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.4.7. Veterinary Antibiotics Market - Italy
      • 8.4.7.1. Italy: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.4.8. Veterinary Antibiotics Market - Spain
      • 8.4.8.1. Spain: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.4.9. Veterinary Antibiotics Market - Netherlands
      • 8.4.9.1. Netherlands: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.4.10. Veterinary Antibiotics Market - Russia
      • 8.4.10.1. Russia: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.4.11. Veterinary Antibiotics Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
  • 8.5. Veterinary Antibiotics Market - Asia Pacific
    • 8.5.1. Asia Pacific: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.5.4. Veterinary Antibiotics Market - China
      • 8.5.4.1. China: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.5.5. Veterinary Antibiotics Market - India
      • 8.5.5.1. India: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.5.6. Veterinary Antibiotics Market - Malaysia
      • 8.5.6.1. Malaysia: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.5.7. Veterinary Antibiotics Market - Japan
      • 8.5.7.1. Japan: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.5.8. Veterinary Antibiotics Market - Indonesia
      • 8.5.8.1. Indonesia: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.5.9. Veterinary Antibiotics Market - South Korea
      • 8.5.9.1. South Korea: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.5.10. Veterinary Antibiotics Market - Australia
      • 8.5.10.1. Australia: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.5.11. Veterinary Antibiotics Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
  • 8.6. Veterinary Antibiotics Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.6.4. Veterinary Antibiotics Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.6.5. Veterinary Antibiotics Market - UAE
      • 8.6.5.1. UAE: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.6.6. Veterinary Antibiotics Market - Israel
      • 8.6.6.1. Israel: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.6.7. Veterinary Antibiotics Market - South Africa
      • 8.6.7.1. South Africa: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.6.8. Veterinary Antibiotics Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
  • 8.7. Veterinary Antibiotics Market - Latin America
    • 8.7.1. Latin America: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.7.4. Veterinary Antibiotics Market - Mexico
      • 8.7.4.1. Mexico: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.7.5. Veterinary Antibiotics Market - Brazil
      • 8.7.5.1. Brazil: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.7.6. Veterinary Antibiotics Market - Argentina
      • 8.7.6.1. Argentina: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.7.7. Veterinary Antibiotics Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Bimeda, Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Boehringer Ingelheim International GmbH
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Calier
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Ceva Sante Animale
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Dechra Pharmaceuticals PLC
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Elanco Animal Health Incorporated
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Merck & Co., Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Norbrook Laboratories
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Prodivet Pharmaceuticals SA/NV
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Vetoquinol
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Virbac S.A.
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Zoetis Services LLC
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development